Immunovia AB (FRA:1YR)
€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Q3 2023 Immunovia AB (publ) Earnings Call Transcript

Nov 09, 2023 / 02:00PM GMT
Release Date Price: €0.156774 (+2.94%)
Operator

Ladies and gentlemen, welcome to the Immunovia Q3 Interim Report 2023 Conference Call. I am George, Chorus Call operator. I would like to remind you that the conference will be recorded. The presentation will be followed by a Q&A session.

(Operator Instructions)

At this time, it's my pleasure to hand over to Karin Almqvist, CFO. Please go ahead.

Karin Almqvist Liwendahl;publ;CFO;Jeff Borcherding;publ
Immunovia AB;Immunovia AB

()-

Thank you so much. Good morning, and good afternoon to you all, and welcome to this conference call following our Third Quarter results. Presenting on the call is Jeff Borcherding, our CEO of Immunovia, and myself, Karin Almqvist, being the CFO of the company. The presentation will be followed by a Q&A session.

(Operator Instructions)

After we have closed today's call, you will find the presentation and recording on our website. With that, I would like to hand over to our CEO, Jeff. Please go ahead.

- ()

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot